PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -15.8% | 20,175 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $57,000 | -23.0% | 20,175 | -21.3% | 0.00% | -33.3% |
| Q1 2022 | $74,000 | -5.1% | 25,636 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $78,000 | -43.5% | 25,688 | +30.8% | 0.00% | -40.0% |
| Q3 2021 | $138,000 | -44.1% | 19,635 | -26.9% | 0.01% | -44.4% |
| Q2 2021 | $247,000 | +118.6% | 26,870 | +130.6% | 0.01% | +125.0% |
| Q1 2021 | $113,000 | -19.9% | 11,652 | -15.1% | 0.00% | -33.3% |
| Q4 2020 | $141,000 | – | 13,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |